# Shanghai Huikai Medical Technology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shanghai-huikai-medical-technology

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Website: www.huikaimed.com
- Total disclosed funding: $3.9M
- Latest round: Series B (Jan 8, 2024)
- Investors on record: 3

## About

Established in 2018 and based in Shanghai, China, Shanghai Huikai Medical Technology is a medical device company that focuses on the development and production of urological platform-based medical devices. The company is headquartered in Shanghai, with an R&D center in Suzhou and a clinical trial site in Wuhan.

The company’s main business is the development and production of medical devices for the urological system. Its products are involved in various segments such as prostate enlargement, stone management, urinary incontinence, urological oncology, and new materials. Their self-developed UroStent® is a prostate stenting system that does not require general anesthesia and does not require the use a cystoscope for positioning and release.

## Funding rounds

- Series B, Jan 8, 2024 — Cathay Capital
- Series A, Aug 19, 2021, $3.9M — YuanBio Venture, Furong Capital

## Investors

- YuanBio Venture (https://capitalatlas.ai/funds/yuanbio-venture) — Series A
- Furong Capital (https://capitalatlas.ai/funds/furong-capital) — Series A
- Cathay Capital — Series B